Archives of Medical Research
Volume 37, Issue 6 , Pages 717-722 , August 2006

Ozone/Oxygen Mixture Modifies the Subcellular Redistribution of Bax Protein in Renal Tissue from Rats Treated with Cisplatin

  • Aluet Borrego

      Affiliations

    • National Laboratory for the Control of Drugs, Havana, Cuba
    • Corresponding Author InformationAddress reprint requests to: Mrs. Aluet Borrego, MSc, Researcher, Center for the Control and Development of Drugs (CECMED), Havana, Cuba;
    • ,
  • Zullyt Barbara Zamora

      Affiliations

    • Ozone Research Center, Center for the Control and Development of Drugs (CECMED), Havana, Cuba
    • ,
  • Ricardo González

      Affiliations

    • Ozone Research Center, Center for the Control and Development of Drugs (CECMED), Havana, Cuba
    • ,
  • Cheyla Romay

      Affiliations

    • Ozone Research Center, Center for the Control and Development of Drugs (CECMED), Havana, Cuba
    • ,
  • Silvia Menéndez

      Affiliations

    • Ozone Research Center, Center for the Control and Development of Drugs (CECMED), Havana, Cuba
    • ,
  • Frank Hernández

      Affiliations

    • Ozone Research Center, Center for the Control and Development of Drugs (CECMED), Havana, Cuba
    • ,
  • Jorge Berlanga

      Affiliations

    • Center for Genetic Engineering and Biotechnology, Biomedical Investigations Branch (CIGB), Havana, Cuba
    • ,
  • Teresita Montero

      Affiliations

    • Department of Histopathology, Dr. Luis Díaz Soto Hospital, Havana, Cuba

Received 9 August 2005 ,Accepted 24 February 2006.

References 

  1. Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer. 1998;34:1522–1534
  2. Sheikh-Hamad D, Cacini W, Bucley AR, Isaac J, Truong LD, Chui Tsao, et al. Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Arch Toxicol. 2004;78:147–155
  3. Hwa Lee R, Mi Song J, Young Park M, Kyung Kang S, Keun Kim Y, Sup Jung J. Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem Pharmacol. 2001;62:1013–1023
  4. Wu YJ, Muldoon LL, Neuwelt EA. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther. 2005;312:424–431
  5. Baliga R, Ueda N, Walker PD. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis. 1997;29:465–477
  6. Hussain KC, Morris C, Whitworth GL. Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system. Mol Cell Biochem. 1998;178:127–133
  7. Appenroth D, Frob S, Kersten L, Splinter FK, Winnefeld K. Protective effect of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol. 1997;71:677–683
  8. Somani SM, Husain K, Whitworth C, Rybak LP. Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol. 2000;86:234–240
  9. Davis CA, Nick HS, Agarwal A. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol. 2001;12:2683–2690
  10. González R, Borrego A, Zamora Z, Romay CH, Hernández F, Menéndez S, et al. Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats. Mediators Inflamm. 2004;13:1–6
  11. Borrego A, Zamora Z, González R, Romay CH, Menéndez S, Hernández F, et al. Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats. Mediators Inflamm. 2004;13:13–19
  12. León OS, Menéndez S, Merino N, Castillo R, Sam S, Perez L, et al. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm. 1998;7:298–294.
  13. Candelario-Jalil E, Mohammed-Al-Dalain S, Fernandez OS, Menendez S, Perez-Davison G, Merino N, et al. Oxidative preconditioning affords protection against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats. J Appl Toxicol. 2001;21:291–301
  14. Al-Dalain SM, Gregorio M, Eduardo C-J, et al. Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res. 2001;44:391–396
  15. Barber E, Menéndez S, León OS, et al. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia. Mediators Inflamm. 1999;8:37–41
  16. Peralta C, León OS, Xaus C, Pratts N, Jalil EC, Plannel ES, et al. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radic Res. 1999;31:191–196
  17. Peralta C, Xaus C, Bartrons R, Leon OS, Gelpi E, Rosello-Catafau J. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Radic Res. 2000;33:595–605
  18. Ajamieh H, Merino N, Candelario-Jalil E, Menendez S, Martinez-Sanchez G, Re L, et al. Similar protective effect of ischaemic and ozone oxidative preconditionings in liver ischaemia/reperfusion injury. Pharmacol Res. 2002;45:333–339
  19. Ajamieh H, Menéndez S, Martínez-Sanchez G, Candelario-Jalil E, Re L, et al. Effects of ozone oxidative preconditioning on nitric oxide generation and redox cellular balance in a rat model of hepatic ischaemia-reperfusion. Liver Int. 2004;24:55–62
  20. Dechao L, Eisaku U, Tsuyoshi K, Tetsuya Y, Tokio O. Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation an ubiquitination. Cancer Sci. 2004;95:644–650
  21. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47–95
  22. Ortiz A, Lorz C, Catalán MP, Danoff TM, Yamasaki Y, Egido J, et al. Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int. 2000;57:969–981
  23. Dobyan DC, Levi J, Jacobs C. Mechanism of cis-platinum nephrotoxicity. II. Morphological observations. J Pharmacol Exp Ther. 1980;213:551–556
  24. Cuttle L, Zhang XJ, Endre ZH, Winterford C, Gobé G. Bcl-XL translocation in renal tubular epithelial cells in vitro protects distal cells from oxidative stress. Kidney Int. 2001;59:1779–1788
  25. Nishita M, Inoue S, Tsuda M, Tateda C, Miyashita T. Nuclear translocation and increased expression of Bax and disturbance in cell cycle progression without prominent apoptosis induced by hyperthermia. Exp Cell Res. 1998;244:357–366
  26. Joy A, Panicker S, Shapiro JR. Altered nuclear localization of bax protein in BCNU-resistant glioma cells. J Neurooncol. 2000;49:117–129
  27. Li L, Oppenheim RW, Milligan CE. Characterization of the execution pathway of developing motoneurons deprived of trophic support. J Neurobiol. 2001;46:249–264
  28. Salah-eldin A, Inoue S, Tsuda M, Matsuura A. Abnormal intracellular localization of Bax with a normal membrane anchor domain in human lung cancer cell lines. Jpn J Cancer Res. 2000;91:1269–1277
  29. Yamamoto CM, Sinha Hikim AP, Huynh PN, Shapiro B, Lue Y, Salameh WA, et al. Redistribution of Bax is an early step in an apoptotic pathway leading to germ cell death in rats, triggered by mild testicular hyperthermia. Biol Reprod. 2000;63:1683–1690
  30. Ajamieh HH, Berlanga J, Merino N, Sánchez GM, Jalil EC, Cepero SM, et al. Role of protein synthesis in the protection conferred by ozone oxidative preconditioning in hepatic ischemia/reperfusion. Transpl Int. 2005;18:604–612
  31. Raffo AJ, Kim AL, Fine RL. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis. Oncogene. 2003;19:6216–6228

PII: S0188-4409(06)00097-X

doi: 10.1016/j.arcmed.2006.02.008

Archives of Medical Research
Volume 37, Issue 6 , Pages 717-722 , August 2006

Article Tools

* Image Usage & Resolution